Literature DB >> 23455005

Siah: a promising anticancer target.

Christina S F Wong1, Andreas Möller.   

Abstract

Siah ubiquitin ligases play important roles in a number of signaling pathways involved in the progression and spread of cancer in cell-based models, but their role in tumor progression remains controversial. Siah proteins have been described to be both oncogenic and tumor suppressive in a variety of patient cohort studies and animal cancer models. This review collates the current knowledge of Siah in cancer progression and identifies potential methods of translation of these findings into the clinic. Furthermore, key experiments needed to close the gaps in our understanding of the role Siah proteins play in tumor progression are suggested. ©2013 AACR.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23455005     DOI: 10.1158/0008-5472.CAN-12-4348

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  27 in total

1.  Identification and characterization of small molecule inhibitors of the ubiquitin ligases Siah1/2 in melanoma and prostate cancer cells.

Authors:  Yongmei Feng; E Hampton Sessions; Fan Zhang; Fuqiang Ban; Veronica Placencio-Hickok; Chen-Ting Ma; Fu-Yue Zeng; Ian Pass; David B Terry; Gregory Cadwell; Laurie A Bankston; Robert C Liddington; Thomas D Y Chung; Anthony B Pinkerton; Eduard Sergienko; Martin Gleave; Neil A Bhowmick; Michael R Jackson; Artem Cherkasov; Ze'ev A Ronai
Journal:  Cancer Lett       Date:  2019-02-14       Impact factor: 8.679

2.  CHK2 stability is regulated by the E3 ubiquitin ligase SIAH2.

Authors:  C García-Limones; M Lara-Chica; C Jiménez-Jiménez; M Pérez; P Moreno; E Muñoz; M A Calzado
Journal:  Oncogene       Date:  2016-01-11       Impact factor: 9.867

3.  Hypoxia regulates Hippo signalling through the SIAH2 ubiquitin E3 ligase.

Authors:  Biao Ma; Yan Chen; Ling Chen; Hongcheng Cheng; Chenglong Mu; Jie Li; Ruize Gao; Changqian Zhou; Lei Cao; Jinhua Liu; Yushan Zhu; Quan Chen; Shian Wu
Journal:  Nat Cell Biol       Date:  2014-12-01       Impact factor: 28.824

4.  Deacetylation of HSPA5 by HDAC6 leads to GP78-mediated HSPA5 ubiquitination at K447 and suppresses metastasis of breast cancer.

Authors:  Y-W Chang; C-F Tseng; M-Y Wang; W-C Chang; C-C Lee; L-T Chen; M-C Hung; J-L Su
Journal:  Oncogene       Date:  2015-06-29       Impact factor: 9.867

5.  Mutual regulation between Polo-like kinase 3 and SIAH2 E3 ubiquitin ligase defines a regulatory network that fine-tunes the cellular response to hypoxia and nickel.

Authors:  Cen Li; Soyoung Park; Xiaowen Zhang; Wei Dai; Dazhong Xu
Journal:  J Biol Chem       Date:  2017-05-17       Impact factor: 5.157

Review 6.  Polo-like kinase 3, hypoxic responses, and tumorigenesis.

Authors:  Dazhong Xu; Wei Dai; Cen Li
Journal:  Cell Cycle       Date:  2017-09-21       Impact factor: 4.534

7.  SIAH2 protein expression in breast cancer is inversely related with ER status and outcome to tamoxifen therapy.

Authors:  Kimberly D van der Willik; Mieke M Timmermans; Carolien Hm van Deurzen; Maxime P Look; Esther A Reijm; Wendy Jhp van Zundert; Renée Foekens; Anita Mac Trapman-Jansen; Michael A den Bakker; Pieter J Westenend; John Wm Martens; Els Mjj Berns; Maurice Phm Jansen
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

8.  Two high-resolution structures of the human E3 ubiquitin ligase Siah1.

Authors:  Vadim Rimsa; Thomas C Eadsforth; William N Hunter
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2013-11-28

9.  Combining techniques for screening and evaluating interaction terms on high-dimensional time-to-event data.

Authors:  Murat Sariyar; Isabell Hoffmann; Harald Binder
Journal:  BMC Bioinformatics       Date:  2014-02-26       Impact factor: 3.169

10.  Siah ubiquitin ligases modulate nodal signaling during zebrafish embryonic development.

Authors:  Nami Kang; Minho Won; Myungchull Rhee; Hyunju Ro
Journal:  Mol Cells       Date:  2014-05-14       Impact factor: 5.034

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.